現代中藥集團 (1643.HK)

0.320 0.000 (0.00%) 收市：03:55PM HKT

現代中藥集團

No. 88, Jinwei Road
Longhua County
Chengde 067000
China
86 31 4716 2222
https://www.cdysjdyy.com

版塊: Healthcare
行業: Drug Manufacturers - General
全職員工: 191

高階主管

名稱	頭銜	支付	行使價	出生年份
Ms. Hongli Zhang	CEO & Executive Director	305.43k	無	1965
Ms. Xinlei Sun	Executive Chairman	無	無	1985
Mr. Wen Tao Li	Chief Financial Officer	無	無	1983
Ms. Tsz Hei Chan	Joint Company Secretary	無	無	1986
Ms. Yanru Jia	Joint Company Secretary & Executive Director	無	無	1983

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China. The company offers therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, respiratory system, and nervous system conditions. It also provides business support, technical, and consulting services. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.

公司管治

截至 無 止，現代中藥集團 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。